Published in Exp Mol Pathol on October 24, 2012
The miR-200 family and the miR-183~96~182 cluster target Foxf2 to inhibit invasion and metastasis in lung cancers. Oncogene (2015) 1.01
A novel chordoma xenograft allows in vivo drug testing and reveals the importance of NF-κB signaling in chordoma biology. PLoS One (2013) 0.83
The how and why of identifying the hair cell mechano-electrical transduction channel. Pflugers Arch (2014) 0.83
Comparative analyses of lung transcriptomes in patients with alveolar capillary dysplasia with misalignment of pulmonary veins and in foxf1 heterozygous knockout mice. PLoS One (2014) 0.78
Molecular and clinical analyses of 16q24.1 duplications involving FOXF1 identify an evolutionarily unstable large minisatellite. BMC Med Genet (2014) 0.77
Accumulation of p53 via down-regulation of UBE2D family genes is a critical pathway for cadmium-induced renal toxicity. Sci Rep (2016) 0.76
Decreased FOXF1 promotes hepatocellular carcinoma tumorigenesis, invasion, and stemness and is associated with poor clinical outcome. Onco Targets Ther (2016) 0.75
Cancer statistics, 2010. CA Cancer J Clin (2010) 103.28
ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia (2004) 17.08
The emerging roles of forkhead box (Fox) proteins in cancer. Nat Rev Cancer (2007) 8.05
Molecular classification of human carcinomas by use of gene expression signatures. Cancer Res (2001) 6.78
Forkhead transcription factors: key players in development and metabolism. Dev Biol (2002) 4.74
Stressing the role of FoxO proteins in lifespan and disease. Nat Rev Mol Cell Biol (2007) 4.73
The evolution of Fox genes and their role in development and disease. Nat Rev Genet (2009) 3.13
Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer. Genome Biol (2007) 2.70
Human FOX gene family (Review). Int J Oncol (2004) 2.63
Haploinsufficiency of the forkhead gene Foxf1, a target for sonic hedgehog signaling, causes lung and foregut malformations. Development (2001) 2.62
Hepatocyte nuclear factor 3/fork head or "winged helix" proteins: a family of transcription factors of diverse biologic function. Proc Natl Acad Sci U S A (1993) 2.47
Modeling oncogenic signaling in colon tumors by multidirectional analyses of microarray data directed for maximization of analytical reliability. PLoS One (2010) 2.32
Foxf1 and Foxf2 control murine gut development by limiting mesenchymal Wnt signaling and promoting extracellular matrix production. Development (2006) 2.01
The forkhead transcription factor Foxf1 is required for differentiation of extra-embryonic and lateral plate mesoderm. Development (2001) 1.95
Foxf1 +/- mice exhibit defective stellate cell activation and abnormal liver regeneration following CCl4 injury. Hepatology (2003) 1.59
Haploinsufficiency of the mouse Forkhead Box f1 gene causes defects in gall bladder development. J Biol Chem (2002) 1.30
Differential activation of lung-specific genes by two forkhead proteins, FREAC-1 and FREAC-2. J Biol Chem (1996) 1.17
Epigenetic inactivation of the potential tumor suppressor gene FOXF1 in breast cancer. Cancer Res (2010) 1.13
Forkhead box F1 regulates tumor-promoting properties of cancer-associated fibroblasts in lung cancer. Cancer Res (2010) 1.11
Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas. Br J Cancer (1994) 1.08
Nuclear Janus-activated kinase 2/nuclear factor 1-C2 suppresses tumorigenesis and epithelial-to-mesenchymal transition by repressing Forkhead box F1. Cancer Res (2010) 1.05
The p53-p21WAF1 checkpoint pathway plays a protective role in preventing DNA rereplication induced by abrogation of FOXF1 function. Cell Signal (2011) 0.89
Current therapies for advanced colorectal cancer. Oncology (Williston Park) (2005) 0.89
The genomic landscapes of human breast and colorectal cancers. Science (2007) 38.12
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature (2010) 23.55
Molecular definition of breast tumor heterogeneity. Cancer Cell (2007) 12.67
Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters. Nat Genet (2011) 5.62
The Hox genes and their roles in oncogenesis. Nat Rev Cancer (2010) 3.97
Heterogeneity of breast cancer metastases: comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastases. Clin Cancer Res (2008) 3.67
Cell type-specific DNA methylation patterns in the human breast. Proc Natl Acad Sci U S A (2008) 2.99
Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene (2003) 2.71
HOXB7, a homeodomain protein, is overexpressed in breast cancer and confers epithelial-mesenchymal transition. Cancer Res (2006) 2.66
The ATM kinase induces microRNA biogenesis in the DNA damage response. Mol Cell (2011) 2.50
Modeling precision treatment of breast cancer. Genome Biol (2013) 2.42
Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer. Cancer Res (2004) 2.29
Store-independent activation of Orai1 by SPCA2 in mammary tumors. Cell (2010) 2.29
DNA methylation regulates MicroRNA expression. Cancer Biol Ther (2007) 2.21
Somatic mutation and gain of copy number of PIK3CA in human breast cancer. Breast Cancer Res (2005) 2.20
DNA methylation of RASSF1A, HIN-1, RAR-beta, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma. Int J Cancer (2003) 2.18
Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrence. Cancer Res (2011) 2.12
The mammalian ortholog of Drosophila MOF that acetylates histone H4 lysine 16 is essential for embryogenesis and oncogenesis. Mol Cell Biol (2007) 2.07
Genetic and phenotypic diversity in breast tumor metastases. Cancer Res (2014) 1.96
Interleukin-6 and cachexia in ApcMin/+ mice. Am J Physiol Regul Integr Comp Physiol (2007) 1.85
Alpha(1)-acid glycoprotein: an acute phase protein with inflammatory and immunomodulating properties. Cytokine Growth Factor Rev (2003) 1.72
Tumor-specific changes in mtDNA content in human cancer. Int J Cancer (2005) 1.70
Alterations in vascular gene expression in invasive breast carcinoma. Cancer Res (2004) 1.68
Clostridium perfringens enterotoxin elicits rapid and specific cytolysis of breast carcinoma cells mediated through tight junction proteins claudin 3 and 4. Am J Pathol (2004) 1.66
Methylated genes in breast cancer: associations with clinical and histopathological features in a familial breast cancer cohort. Cancer Biol Ther (2011) 1.62
RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer. Cancer Res (2006) 1.60
Quantitative multiplex methylation-specific PCR analysis doubles detection of tumor cells in breast ductal fluid. Clin Cancer Res (2006) 1.58
Myeloid progenitor cells in the premetastatic lung promote metastases by inducing mesenchymal to epithelial transition. Cancer Res (2012) 1.57
SLITs suppress tumor growth in vivo by silencing Sdf1/Cxcr4 within breast epithelium. Cancer Res (2008) 1.52
HOXA5-induced apoptosis in breast cancer cells is mediated by caspases 2 and 8. Mol Cell Biol (2004) 1.44
Mitoxantrone mediates demethylation and reexpression of cyclin d2, estrogen receptor and 14.3.3sigma in breast cancer cells. Cancer Biol Ther (2003) 1.44
Hemoglobin and its scavenger protein haptoglobin associate with apoA-1-containing particles and influence the inflammatory properties and function of high density lipoprotein. J Biol Chem (2009) 1.42
Gene expression profiling of human breast tissue samples using SAGE-Seq. Genome Res (2010) 1.41
Decreased intestinal polyp multiplicity is related to exercise mode and gender in ApcMin/+ mice. J Appl Physiol (1985) (2005) 1.39
Ductal access for prevention and therapy of mammary tumors. Cancer Res (2006) 1.38
Oncogenic Wip1 phosphatase is inhibited by miR-16 in the DNA damage signaling pathway. Cancer Res (2010) 1.37
Very high frequency of hypermethylated genes in breast cancer metastasis to the bone, brain, and lung. Clin Cancer Res (2004) 1.35
Enhanced splenomegaly and severe liver inflammation in haptoglobin/hemopexin double-null mice after acute hemolysis. Blood (2002) 1.34
Molecular pathways: current role and future directions of the retinoic acid pathway in cancer prevention and treatment. Clin Cancer Res (2013) 1.30
Identification of transcriptional targets of HOXA5. J Biol Chem (2005) 1.27
Muscle wasting and interleukin-6-induced atrogin-I expression in the cachectic Apc ( Min/+ ) mouse. Pflugers Arch (2008) 1.27
USP4 inhibits p53 through deubiquitinating and stabilizing ARF-BP1. EMBO J (2011) 1.26
HMGA1: a master regulator of tumor progression in triple-negative breast cancer cells. PLoS One (2013) 1.25
Hypermethylation in histologically distinct classes of breast cancer. Clin Cancer Res (2004) 1.25
Targeted knockout of BRG1 potentiates lung cancer development. Cancer Res (2008) 1.24
The HOXB7 protein renders breast cancer cells resistant to tamoxifen through activation of the EGFR pathway. Proc Natl Acad Sci U S A (2011) 1.24
Epigenomics and breast cancer. Pharmacogenomics (2008) 1.23
Adenocarcinoma of the small intestine: a multi-institutional study of 197 surgically resected cases. Hum Pathol (2010) 1.22
Hoxb7 inhibits transgenic HER-2/neu-induced mouse mammary tumor onset but promotes progression and lung metastasis. Cancer Res (2008) 1.20
Novel methylated biomarkers and a robust assay to detect circulating tumor DNA in metastatic breast cancer. Cancer Res (2014) 1.19
Sodium-coupled transport of the short chain fatty acid butyrate by SLC5A8 and its relevance to colon cancer. J Gastrointest Surg (2008) 1.19
Epigenetic suppression of secreted frizzled related protein 1 (SFRP1) expression in human breast cancer. Cancer Biol Ther (2006) 1.19
Epithelial cell adhesion molecule (EpCAM) is overexpressed in breast cancer metastases. Breast Cancer Res Treat (2009) 1.17
MYC gene amplification is often acquired in lethal distant breast cancer metastases of unamplified primary tumors. Mod Pathol (2011) 1.15
Epigenetic regulation of cell type-specific expression patterns in the human mammary epithelium. PLoS Genet (2011) 1.15
Primary epithelial ovarian carcinoma with gastric metastasis mimic gastrointestinal stromal tumor. Cancer Res Treat (2008) 1.15
Molecular profiling of human mammary gland links breast cancer risk to a p27(+) cell population with progenitor characteristics. Cell Stem Cell (2013) 1.14
A role for the HOXB7 homeodomain protein in DNA repair. Cancer Res (2007) 1.14
Hyaluronan constitutively regulates activation of COX-2-mediated cell survival activity in intestinal epithelial and colon carcinoma cells. J Biol Chem (2008) 1.13
Effects of ligand binding and conformational switching on intracellular stability of human thymidylate synthase. Biochim Biophys Acta (2004) 1.13
Epigenetic inactivation of the potential tumor suppressor gene FOXF1 in breast cancer. Cancer Res (2010) 1.13
A case of multiple mucosa-associated lymphoid tissue (MALT) lymphoma of the colon identified as simple mucosal discoloration. J Korean Med Sci (2005) 1.12
Role of homeobox genes in normal mammary gland development and breast tumorigenesis. J Mammary Gland Biol Neoplasia (2003) 1.11
Racial disparities in advanced-stage colorectal cancer survival. Cancer Causes Control (2013) 1.10
The acute phase protein haptoglobin regulates host immunity. J Leukoc Biol (2008) 1.10
Estrogen receptor/progesterone receptor-negative breast cancers of young African-American women have a higher frequency of methylation of multiple genes than those of Caucasian women. Clin Cancer Res (2004) 1.10
Role of N-terminal residues in the ubiquitin-independent degradation of human thymidylate synthase. Biochem J (2006) 1.09
Preclinical and clinical evaluation of intraductally administered agents in early breast cancer. Sci Transl Med (2011) 1.09
Functional activation of the estrogen receptor-α and aromatase by the HDAC inhibitor entinostat sensitizes ER-negative tumors to letrozole. Cancer Res (2011) 1.09
The interaction of a high-fat diet and regular moderate intensity exercise on intestinal polyp development in Apc Min/+ mice. Cancer Prev Res (Phila) (2009) 1.09
Distant metastasis in breast cancer: molecular mechanisms and therapeutic targets. Cancer Biol Ther (2003) 1.08
Collagen I fiber density increases in lymph node positive breast cancers: pilot study. J Biomed Opt (2012) 1.08
Altered antisense-to-sense transcript ratios in breast cancer. Proc Natl Acad Sci U S A (2010) 1.08
Developmental abnormalities in multiple proliferative tissues of Apc(Min/+) mice. Int J Exp Pathol (2006) 1.07
Complete radiographic response of primary pulmonary angiosarcomas following gemcitabine and taxotere. Lung Cancer (2008) 1.07
Clostridium perfringens enterotoxin as a novel-targeted therapeutic for brain metastasis. Cancer Res (2007) 1.07
Myofiber degeneration/regeneration is induced in the cachectic ApcMin/+ mouse. J Appl Physiol (1985) (2005) 1.07
HOXA5 acts directly downstream of retinoic acid receptor beta and contributes to retinoic acid-induced apoptosis and growth inhibition. Cancer Res (2007) 1.06
Somatic mutations in the Notch, NF-KB, PIK3CA, and Hedgehog pathways in human breast cancers. Genes Chromosomes Cancer (2012) 1.06
Hypermethylated genes as biomarkers of cancer in women with pathologic nipple discharge. Clin Cancer Res (2009) 1.05
HOX genes: emerging stars in cancer. Cancer Biol Ther (2003) 1.05
Period 2 mutation accelerates ApcMin/+ tumorigenesis. Mol Cancer Res (2008) 1.05
HOXB13 mediates tamoxifen resistance and invasiveness in human breast cancer by suppressing ERα and inducing IL-6 expression. Cancer Res (2013) 1.05
Ovarian neuroendocrine carcinoma, non-small cell type, associated with serous carcinoma. Gynecol Oncol (2007) 1.03
Assessment of DNA methylation for the detection of cervical neoplasia in liquid-based cytology specimens. Gynecol Oncol (2010) 1.03
Linking tumor-associated macrophages, inflammation, and intestinal tumorigenesis: role of MCP-1. Am J Physiol Gastrointest Liver Physiol (2012) 1.02
DNA methylation-related vitamin D receptor insensitivity in breast cancer. Cancer Biol Ther (2010) 1.02
A Dynamic Blood Information Management System Based on RFID. Conf Proc IEEE Eng Med Biol Soc (2005) 1.02
Structural determinants for the intracellular degradation of human thymidylate synthase. Biochemistry (2004) 1.01
Identification of biomarkers for breast cancer in nipple aspiration and ductal lavage fluid. Clin Cancer Res (2005) 1.00
Activity level, apoptosis, and development of cachexia in Apc(Min/+) mice. J Appl Physiol (1985) (2010) 1.00
The intrinsically disordered N-terminal domain of thymidylate synthase targets the enzyme to the ubiquitin-independent proteasomal degradation pathway. J Biol Chem (2009) 0.99